GSDMD and Sepsis: Disulfiram, an FDA-approved medication for alcohol abuse treatment, can covalently bind to hC191/mC192 within GSDMD through cysteine modification, thereby reducing pore formation in an animal model of LPS-induced sepsis 36 (Figure 3).